Practitioner’s Guide to Psychoactive Drugs for Children and AdolescentsJohn Scott Werry, Michael G. Aman Springer Science & Business Media, 29 de juny 2013 - 502 pàgines Incorporating the latest developments in pharmacology and therapy, this fully revised Second Edition is an ideal quick reference for those who prescribe psychotrophic drugs for young people. New and notable features include:
|
Continguts
3 | |
Pharmacology | 23 |
A Enzymes | 43 |
Prevalence of Drug Therapy | 51 |
Monitoring and Measuring Drug Effects I Physical Effects | 69 |
Monitoring and Measuring Drug Effects II Behavioral Emotional | 99 |
Medicolegal and Ethical Issues in the Pharmacological Treatment | 165 |
Risk Management in the Treatment of Children and Adolescents | 177 |
Pharmacology | 307 |
SummaryConclusions | 319 |
Drugs of Abuse | 329 |
Antiepileptics Anticonvulsants | 355 |
Psychoactive Effects of Medical Drugs | 387 |
Developmental Considerations | 407 |
Nootropics and Foods | 413 |
Anxiolytics Sedatives and Miscellaneous Drugs | 433 |
Stimulants | 213 |
Antidepressant and Antimanic Drugs | 249 |
Antipsychotics Neuroleptics | 297 |
Appendix A Psychoactive Medications Grouped by Drug Class and Foods | 471 |
Altres edicions - Mostra-ho tot
Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents John S. Werry,Michael G. Aman Previsualització limitada - 2013 |
Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents John Scott Werry,Michael G. Aman Previsualització limitada - 1998 |
Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents John S. Werry,Michael G. Aman Visualització de fragments - 1993 |
Frases i termes més freqüents
abnormal Acad Child Adolesc ADHD adults aggression Aman MG antidepressants antiepileptic antipsychotics anxiety disorders Arch Gen Psychiatry assessment associated attention deficit attention-deficit hyperactivity disorder autism behavior benzodiazepines bipolar blood levels brain carbamazepine Chapter Child Adolesc Psychiatry Child Adolesc Psychopharmacol child and adolescent Child Psychol childhood children and adolescents chlorpromazine Clin clinical clinician clomipramine clonidine clozapine cognitive concentration Conners depression desipramine dextroamphetamine diagnostic dosage dose double-blind drug effects DSM-IV dyskinesia efficacy epilepsy fenfluramine fluoxetine function haloperidol hyperactivity disorder imipramine increased lithium medication mental retardation metabolism methylphenidate mg/kg monitoring mood neuroleptics Nootropic parents patients pediatric psychopharmacology pharmacological pharmacotherapy phenobarbital phenytoin physician piracetam placebo plasma potential prescribed problems Psychiatry psychoactive drugs Psychopharmacol Bull Psychopharmacology psychotropic Rating Scale receptor reported response risperidone schizophrenia sedation seizures serotonin side effects SSRIs stimulants studies subscales substance abuse symptoms syndrome TCAs tests therapeutic therapy Tourette syndrome Tourette's toxicity treated treatment valproate Werry